Craneware: trading in-line
Craneware (LON: CRW), the market leader in Value Cycle solutions for the US healthcare market, commented on a strong performance for its first half ending 31 December 2020.
Increased sales momentum resulted in growth at both the revenue and adjusted EBITDA levels of greater than 5% compared to the first half of the prior year (HY20 Revenue: $35.9m, adjusted EBITDA $12.7m).
The Group's customer retention rate has remained above 90% and the dollar…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Bonhill Group
09/06/2023 · Company Insights
Reassuring interim results, expertise in AI and news of share buy-backs has lifted the shares of…
24/05/2023 · Company Insights
The valuations of two companies covered in our free update here are tough to assess and…
More on Craneware
18/07/2025 · Company Insights
Hot on the heels of its first acquisition, a retailer of fresh cream cakes is chancing…
27/06/2025 · Company Insights
News covered here included our assessment of results from a provider of software to the public…
More on Mission Group
25/10/2023 · Company Insights
News covered in our free update here includes an unexpected profit warning from a communications agency…
29/09/2023 · Company Insights
News covered here includes our thoughts on results from several modestly valued companies from the marketing…
More on Mortgage Advice Bureau
22/05/2025 · Company Insights
News covered here includes our assessment of interim results from a very high-quality company. We consider…
04/02/2025 · Company Insights
News covered in the update here includes our assessment of impressive results from one of our…
More Company Insights
Stunning growth, but can it continue?
Another year of strong growth and greater ambition
Full year in-line and cash builds
More on Bonhill Group
More on Craneware
More on Mission Group
More on Mortgage Advice Bureau
More Company Insights